COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,761 Articles (22,502 medRxiv, 8,259 bioRxiv)

Most recent first Previous |  Page 554: Articles 5531-5540  | Next

Serology assays used in SARS-CoV-2 seroprevalence surveys worldwide: a systematic review and meta-analysis of assay features, testing algorithms, and performance
Ma, X., Li, Z., Whelan, M. G., Kim, D., Cao, C., Yanes-Lane, M., Yan, T., Jaenisch, T., Chu, M. C., Clifton, D. A., Subissi, L., Bobrovitz, N., Arora, R. K.
10.1101/2022.10.13.22280957 — Posted: 2022-10-15
Stability of SARS-CoV-2 spike antigens against mutations
Martinez De la Fuente, I., Malaina, I., Fedetz, M., Chruszcz, M., Grandes, G., Targoni, O., Lozano-Perez, A. A., Shteyer, E., Ben Ya'akov, A., Gomez de la Camara, A., M. Borobia, A., Carrasco-Pujante, J., Ignacio Pijoan, J., Bringas, C., Perez-Yarza, G., Ouro, A., Crawford, M. J., Shoshan-Barmatz, V., Zhurov, V., Lopez, J. I., Knafo, S., Tary-Lehmann, M., Gabaldon, T., Grbic, M.
10.1101/2022.10.13.22280980 — Posted: 2022-10-15
A NURSING PHILOSOPHY OF CHRONIC DISEASE SERVICES-BASED PALLIATIVE CARE NURSING DURING COVID-19
Nimah, L., Pandin, M. G. R., Nursalam, N.
10.1101/2022.10.11.22280891 — Posted: 2022-10-15
Computational Prediction of Binding Affinities of Human Angiotensin Converting Enzyme-2 with SARS-CoV-2 Spike Protein Variants: Omicron Variants and Potentially Deleterious Mutations
Williams, A., Zhan, C.-G.
10.1101/2022.10.14.512203 — Posted: 2022-10-14
Broad SARS-CoV-2 Neutralization by Monoclonal and Bispecific Antibodies Derived from a Gamma-infected Individual
Guerra, D., Beaumont, T., Radic, L., Kerster, G., van der Straten, K., Yuan, M., Torres, J. L., Lee, W.-H., Liu, H., Poniman, M., Bontjer, I., Burger, J. A., Claireaux, M., Caniels, T. G., Snitselaar, J. L., Bijl, T. P. L., Kruijer, S., Ozorowski, G., Gideonse, D., Sliepen, K., Ward, A. B., Eggink, D., de Bree, G. J., Wilson, I. A., Sanders, R. W., van Gils, M. J.
10.1101/2022.10.14.512216 — Posted: 2022-10-14
SARS-CoV-2 immune complex triggers human monocyte necroptosis
Santos, L., Antunes, K. H., Cassao, G., Goncalves, J. I., Abbadi, B. L., Bizarro, C. V., Basso, L. A., Machado, P., Souza, A. P. D. d., Porto, B.
10.1101/2022.10.13.512127 — Posted: 2022-10-14
Rapid transmission and tight bottlenecks constrain the evolution of highly transmissible SARS-CoV-2 variants
Bendall, E. E., Callear, A., Getz, A., Goforth, K., Edwards, D., Monto, A., Martin, E. T., Lauring, A. S.
10.1101/2022.10.12.511991 — Posted: 2022-10-14
Role of spike in the pathogenic and antigenic behavior of SARS-CoV-2 BA.1Omicron
Chen, D.-Y., Kenney, D., Chin, C.-V., Tavares, A. H., Khan, N., Conway, H. L., Liu, G., Choudhary, M. C., Gertje, H. P., OConnell, A. K., Kotton, D. N., Herrmann, A., Ensser, A., Connor, J. H., Bosmann, M., Li, J. Z., Gack, M. U., Baker, S. C., Kirchdoerfer, R. N., Kataria, Y., Crossland, N. A., Douam, F., Saeed, M.
10.1101/2022.10.13.512134 — Posted: 2022-10-14
Atypical B cells and impaired SARS-CoV-2 neutralisation following booster vaccination in the elderly.
Ferreira, I. A. T. M., Lee, C. Y. C., Foster, W., Abdullahi, A., Tuong, Z. K., Stewart, B. J., Ferdinand, J. R., Guillaume, S., Potts, M. O. P., Perera, M., Krishna, B. A., Alonso, A. P., Cabantous, M., Kemp, S. A., Ceron-Gutierrez, L., Ebrahimi, S., The CITIID- NIHR BioResource COVID-19 Collaboration, , Lyons, P., Smith, K. G. C., Bradley, J., Collier, D. A., Teichmann, S. A., McCoy, L. E., MacAry, P. A., Doffinger, R., Wills, M. R., Linterman, M., Clatworthy, M. R., Gupta, R. K.
10.1101/2022.10.13.22281024 — Posted: 2022-10-13
Understanding mental health trends during COVID-19 pandemic in the United States using network analysis
Kobayashi, H., Saenz-Escarcega, R., Fulk, A., Agusto, F.
10.1101/2022.10.10.22280933 — Posted: 2022-10-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).